Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Parham

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
Blood|June 28, 2008
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-responseMakoto Yawata, Nobuyo Yawata, Monia Draghi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptorsJohn A Hammond, Lisbeth A Guethlein, Laurent Abi-Rached, et al.
Nucleic Acids Research|November 13, 2010
The IMGT/HLA databaseJames Robinson, Kavita Mistry, Hamish McWilliam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3Achim K Moesta, Paul J Norman, Makoto Yawata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2017
Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-CHugo G Hilton, Jeroen H Blokhuis, Lisbeth A Guethlein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2017
Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA DamageJason L Pugh, Neda Nemat-Gorgani, Paul J Norman, et al.
Human Immunology|April 28, 2007
Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantationKarina L McQueen, Kristel M Dorighi, Lisbeth A Guethlein, et al.
Nucleic Acids Research|October 20, 2012
The IMGT/HLA databaseJames Robinson, Jason A Halliwell, Hamish McWilliam, et al.
Life Science Alliance|November 15, 2019
In vitro education of human natural killer cells by KIR3DL1Jason Pugh, Neda Nemat-Gorgani, Zakia Djaoud, et al.
Journal of Immunological Methods|June 23, 2015
The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assayHugo G Hilton, Achim K Moesta, Lisbeth A Guethlein, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Blood|June 28, 2008
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-responseMakoto Yawata, Nobuyo Yawata, Monia Draghi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptorsJohn A Hammond, Lisbeth A Guethlein, Laurent Abi-Rached, et al.
Nucleic Acids Research|November 13, 2010
The IMGT/HLA databaseJames Robinson, Kavita Mistry, Hamish McWilliam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3Achim K Moesta, Paul J Norman, Makoto Yawata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2017
Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-CHugo G Hilton, Jeroen H Blokhuis, Lisbeth A Guethlein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2017
Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA DamageJason L Pugh, Neda Nemat-Gorgani, Paul J Norman, et al.
Human Immunology|April 28, 2007
Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantationKarina L McQueen, Kristel M Dorighi, Lisbeth A Guethlein, et al.
Nucleic Acids Research|October 20, 2012
The IMGT/HLA databaseJames Robinson, Jason A Halliwell, Hamish McWilliam, et al.
Life Science Alliance|November 15, 2019
In vitro education of human natural killer cells by KIR3DL1Jason Pugh, Neda Nemat-Gorgani, Zakia Djaoud, et al.
Journal of Immunological Methods|June 23, 2015
The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assayHugo G Hilton, Achim K Moesta, Lisbeth A Guethlein, et al.
Pageof 18